跳至主要内容
临床试验/CTRI/2022/02/040587
CTRI/2022/02/040587尚未招募3 期

RANDOMISED CONTROLLED CLINICAL STUDY OF AROGYAMISHRAN ANDTANKANAMISHRAN IN DADRU W.S.R. TO TINEA

Dr Suryakiran Parashuram Wagh2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2022年1月3日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
120
试验地点
2
主要终点
Cure of Dadru kushta signs and symptoms Kandu (Pruritus)

研究概览

简要总结

Background of study is that Dadru wsr Tinea infections recurrence is high, there is need of long standing solution to avoid the recurrence of the disease. This is randomised controlled open clinical trial. both arms with 60 patients intervention for 15 days. Expected primary outcome is patients will became sign and symptom free and secondary outcome will that there should not be recurrence for 6 months.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
14.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients having the clinical features of dadru.
  • Patients ready to abide trial procedure to give informed consent.

排除标准

  • Patients aged below 14 & above 60 years.
  • Pregnant women & lactating mothers.
  • Patient of other skin disease like psoriasis, seborrhic dermatitis, lichen simplex, chronicus, pityriasis versicolor, eczema, candidiasis.
  • Patients having any known severe systemic diseases of renal, hepatic cardiac disorders, diabeties mellitus, tuberculosis, immuno deficiency syndrome, leprosy, malignant disease.
  • 5.Patients having known drug allergy of sulphur, mercury.

结局指标

主要结局

Cure of Dadru kushta signs and symptoms Kandu (Pruritus)

时间窗: 2 months

Raga (Erythema)

时间窗: 2 months

Number of Mandala

时间窗: 2 months

Size of Mandala

时间窗: 2 months

次要结局

  • no recurrence of Dadru(4 weeks)

研究者

发起方
Dr Suryakiran Parashuram Wagh
申办方类型
Other [self]

研究点 (2)

Loading locations...

相似试验